Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Aim. The aim of this paper is to evaluate the effectiveness of low dose cytarabine (Ara-C) combined with cladribine for the treatment of relapsed or refractory acute myeloid leukemia (AML) and to determine clinical and lab factors associated with response to the therapy. Methods. Data of 10 patie...

Full description

Bibliographic Details
Main Authors: SV Gritsaev, II Kostroma, AA Kuzyaeva, IM Zapreeva, EV Litvinskaya, LV Stel’mashenko, SA Tiranova, IS Martynkevich, NA Potikhonova, KM Abdulkadyrov
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-01-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
acute myeloid leukemia
relapse
refractory
chemotherapy
low dose cytarabine
cladribine
Online Access:http://bloodjournal.ru/en/low-dose-cytarabine-and-cladribine-for-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-clinical-experience/

Internet

http://bloodjournal.ru/en/low-dose-cytarabine-and-cladribine-for-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-clinical-experience/

Similar Items